HMGB1, Human, ELISA Kit

データシート

• 商品コード：ARG81185
• メーカー：ARI
• 包装：1kit
• 価格： ¥152,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Di X et al. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma. J. Gastroenterol. Hepatol. 2018 Jul;
  Di X et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 2
• 文献情報：
  Riegger J et al. Evidence of necroptosis in osteoarthritic disease: investigation of blunt mechanical impact as possible trigger in regulated necrosis. Cell Death Dis 2019 Sep;10(10):683
  Riegger J et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 3
• 文献情報：
  Volchuk A et al. Indirect regulation of HMGB1 release by gasdermin D. Nat Commun 2020 09;11(1):4561
  Volchuk A et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 4
• 文献情報：
  Wang Z et al. Tumor-derived HMGB1 induces CD62L^dim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer. Oncogenesis 2020 Sep;9(9):82
  Wang Z et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 5
• 文献情報：
  Li Z et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res 2022 Feb;41(1):74
  Li Z et al
  2022/01/01
  
• 備考：
  
• 参照：
  

• No.： 6
• 文献情報：
  Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity., Biorxiv
  
  
• 備考：
  
• 参照：
  

• No.： 7
• 文献情報：
  Li L et al. Zinc-Loaded Black Phosphorus Multifunctional Nanodelivery System Combined With Photothermal Therapy Have the Potential to Treat Prostate Cancer Patients Infected With COVID-19. Front Endocrinol (Lausanne) 2022;13:872411
  Li L et al
  2022/01/01
  
• 備考：
  
• 参照：
  

• No.： 8
• 文献情報：
  Yamaki H et al. Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. Cancer Immunol Immunother 2023 Aug;72(8):2799-2812
  Yamaki H et al
  2023/01/01
  
• 備考：
  Reactivity: Human / Cell culture supernatant, Application: ELISA
• 参照：
  

• No.： 9
• 文献情報：
  Sabrina S et al. Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma. Biomedicines 2023 Apr;11(5)
  Sabrina S et al
  2023/01/01
  
• 備考：
  Reactivity: Human / Plasma, Application: ELISA
• 参照：
  

• No.： 10
• 文献情報：
  Yan F et al. Identifying TNF and IL6 as potential hub genes and targeted drugs associated with scleritis: A bio-informative report. Front Immunol 2023;14:1098140
  Yan F et al
  2023/01/01
  
• 備考：
  Reactivity: Human / serum , Application: ELISA
• 参照：
  

• No.： 11
• 文献情報：
  Jung E et al. Tumor-targeted redox-regulating and antiangiogenic phototherapeutics nanoassemblies for self-boosting phototherapy. Biomaterials 2023 Jul;298:122127
  Jung E et al
  2023/01/01
  
• 備考：
  Reactivity: Human / Cell culture supernatants, Application: ELISA
• 参照：
  

• No.： 12
• 文献情報：
  Jung E et al. Self-deliverable and self-immolative prodrug nanoassemblies as tumor targeted nanomedicine with triple cooperative anticancer actions. Biomaterials 2022 Aug;287:121681
  Jung E et al
  2022/01/01
  
• 備考：
  Reactivity: Human / Plasma, Application: ELISA
• 参照：
  

• No.： 13
• 文献情報：
  Yasuda K et al. AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. J Autoimmun 2024 Jan;142:103149
  Yasuda K et al
  2024/01/01
  
• 備考：
  Reactivity: Human / Serum, Application: ELISA
• 参照：
  

• No.： 14
• 文献情報：
  Hurtado-Navarro L et al. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. Cell Rep Med 2023 Dec;4(12):101329
  Hurtado-Navarro L et al
  2023/01/01
  
• 備考：
  Reactivity: Human / Plasma, Application: ELISA
• 参照：
  

• No.： 15
• 文献情報：
  Yang G et al. HMGB1 induces macrophage pyroptosis in chronic endometritis. Int Immunopharmacol 2023 Oct;123:110706
  Yang G et al
  2023/01/01
  
• 備考：
  Reactivity: Human / Supernatant, Application: ELISA
• 参照：
  

• No.： 16
• 文献情報：
  Cho SB et al. Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer. In Vivo 2024;38(1):474-481
  Cho SB et al
  2024/01/01
  
• 備考：
  Reactivity: Human / serum, Application: ELISA
• 参照：
  

• No.： 17
• 文献情報：
  Huang J et al. High mobility group box 1 promotes endometriosis under hypoxia by regulating inflammation and autophagy in vitro and in vivo. Int Immunopharmacol 2024 Jan;127:111397
  Huang J et al
  2024/01/01
  
• 備考：
  Reactivity: Human / Cell culture supernatant, Application: ELISA
• 参照：
  

• No.： 18
• 文献情報：
  Guo J et al. Modulation of immune-responses by DSF/Cu enhances the anti-tumor effects of DTX for metastasis breast cancer. J Cancer 2024;15(6):1523-1535
  Guo J et al
  2024/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA / Cell culture supernatants
• 参照：
  

• No.： 19
• 文献情報：
  Kang L et al. High mobility group box-1 protects against Aflatoxin G₁-induced pulmonary epithelial cell damage in the lung inflammatory environment. Toxicol Lett 2020 Oct;331:92-101
  Kang L et al
  2020/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA
• 参照：
  

• No.： 20
• 文献情報：
  Chen Q et al. High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. J Hepatobiliary Pancreat Sci 2020 Aug;27(8):522-530
  Chen Q et al
  2020/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA
• 参照：
  

• No.： 21
• 文献情報：
  Jiao B et al. The role of HMGB1 on TDI-induced NLPR3 inflammasome activation via ROS/NF-κB pathway in HBE cells. Int Immunopharmacol 2021 Sep;98:107859
  Jiao B et al
  2021/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA
• 参照：
  

• No.： 22
• 文献情報：
  Byun JK et al. ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger's disease. Eur Rev Med Pharmacol Sci 2021 Jun;25(11):4051-4063
  Byun JK et al
  2021/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA
• 参照：
  

• No.： 23
• 文献情報：
  Makris G et al. Increased Serum Concentrations of High Mobility Group Box 1 (HMGB1) Protein in Children with Autism Spectrum Disorder. Children (Basel) 2021 Jun;8(6)
  Makris G et al
  2021/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA
• 参照：
  

• No.： 24
• 文献情報：
  Jung E et al. Tumor-Targeting H₂O₂-Responsive Photosensitizing Nanoparticles with Antiangiogenic and Immunogenic Activities for Maximizing Anticancer Efficacy of Phototherapy. ACS Appl Bio Mater 2021 May;4(5):4450-4461
  Jung E et al
  2021/01/01
  
• 備考：
  Reactivity: Human, Application: ELISA
• 参照：
  

• No.： 25
• 文献情報：
  Garc鱈a-Villalba J et al. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol 2022;13:894470
  Garc鱈a-Villalba J et al
  2022/01/01
  
• 備考：
  Reactivity: Human - Cell culture supernatants, Application: ELISA
• 参照：
  

• No.： 26
• 文献情報：
  Kawase A et al. Diclofenac-Induced Cytotoxicity in Direct and Indirect Co-Culture of HepG2 Cells with Differentiated THP-1 Cells. Int J Mol Sci 2022 Aug;23(15)
  Kawase A et al
  2022/01/01
  
• 備考：
  Reactivity: Human / Cell culture supernatant, Application: ELISA
• 参照：
  

• No.： 27
• 文献情報：
  Wang X et al. Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells. Res Sq 2023 Aug;
  Wang X et al
  2023/01/01
  
• 備考：
  Reactivity: Human / Cell culture supernatant, Application: ELISA
• 参照：
  

• No.： 28
• 文献情報：
  Chen F et al. SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis. Biomark Res 2025 Jan;13(1):8
  Chen F et al
  2025/01/01
  
• 備考：
  Reactivity: Human / Cell culture supernatant, Application: ELISA
• 参照：